Imago Biosciences Inc (IMGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,293 | 22,772 | 8,259 | 11,226 | 85,209 |
| Marketable Securities | 171,121 | 167,238 | 197,564 | 206,184 | 145,144 |
| TOTAL | $182,040 | $192,572 | $208,982 | $221,304 | $234,598 |
| Non-Current Assets | |||||
| PPE Net | 2 | 3 | 4 | 2 | 7 |
| Other Non-Current Assets | 4,415 | 3,536 | 3,460 | 3,480 | 2,670 |
| TOTAL | $4,417 | $3,539 | $3,464 | $3,482 | $2,677 |
| Total Assets | $186,457 | $196,111 | $212,446 | $224,786 | $237,275 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,898 | 2,584 | 3,325 | 3,459 | 1,905 |
| Accrued Expenses | 9,940 | 6,189 | 9,609 | 6,633 | 7,006 |
| TOTAL | $13,838 | $8,773 | $12,934 | $10,092 | $8,911 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $13,838 | $8,773 | $12,934 | $10,092 | $8,911 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,822 | 33,742 | 33,736 | 33,707 | 33,529 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -159,564 | -142,788 | -129,047 | -112,653 | -97,927 |
| Other shareholders' equity | -816 | -828 | -636 | -43 | 16 |
| TOTAL | $172,619 | $187,338 | $199,512 | $214,694 | $228,364 |
| Total Liabilities And Equity | $186,457 | $196,111 | $212,446 | $224,786 | $237,275 |